top of page

Mission

The Antimicrobial Stewardship Program aims to optimize antimicrobial effectiveness using a structured institutional approach while minimizing the potential for adverse events, antimicrobial drug resistance and costs. 

Objectives 

  • Advising best practice policies and guidelines for the use of antimicrobial agents at the MUHC;

  • Educating health professionals on matters related to antimicrobials and their appropriate use;

  • Tracking (surveillance) antimicrobial use within the institution;

  • Reporting (feedback) information on antibiotic use and resistance profiles to relevant clinical and administrative staff;

  • Researching the impact of specific interventions on antimicrobial use in the MUHC.

ASP Committee Members 

Makeda Semret*

MD MSc FRCP(C) Chair 

Infectious Diseases and Medical Microbiology

Gary Lee

MD FRCP(C) 

Emergency Medicine

Daniel Thirion* 

BPharm, MSc, PharmD, FCSHP

Pharmacy 

Vivian Loo 

MD MSc FRCP(C) 

Infectious Diseases and Medical Microbiology

Anne Marie Bourgault* 

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Ruth Horn*

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Donald C. Vinh

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Todd C. Lee

MD MPH FRCP(C)

Internal Medicine and Infectious Diseases 

Marc Dobrescu*

PharmD, MSc

Pharmacy

Tarek Razek

MD CM FRCSC FACS

Trauma and General Surgery

Director of the Adult Trauma Program

Charles Frenette* 

MD FRCP(C)

Infection Prevention and Control (Chair)

Samuel De l'Étoile-Morel

MD FRCP(C)

Chief Resident Infectious Diseases and Medical Microbiology

François Bourdeau* 

PharmD, MSc 

Pharmacy 

Co-Chair and Coordinator

Kelly Davison

MD FRCP(C)

Hematology-Oncology 

Salman Qureshi

MD FRCP(C)

Respiratory Medicine and Critical Medicine

Nandini Dendukuri

PhD

Centre for Outcome Research and Evaluation

Raphaëlle Lauly*

BPharm, MSc

Pharmacy

Van Dong Nguyen*

PharmD, MSc

Pharmacy

Derek Lee*

BPharm, PharmD

Pharmacy

Alexandre Rivard*

PharmD, MSc

Pharmacy

Kym Archambault*

PharmD, MSc, BCPS

Pharmacy

Sylvie Carle

BPharm, MSc, FOPQ

Pharmacy

Céline Dupont

BPharm, MSc

Pharmacy

Sébastien Landry*

PharmD, MSc

Pharmacy

The ASP team is accountable to the ASP committee, which in turn is directly accountable to the MUHC Director of Infectious Diseases (ID) and the Chief of Pharmacy.

*Also part of the ASP audit team. 
Makeda Semret: makeda.semret@mcgill.ca
François Bourdeau: francois.bourdeau@muhc.mcgill.ca
bottom of page